1. Home
  2. TERN vs HCAT Comparison

TERN vs HCAT Comparison

Compare TERN & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TERN
  • HCAT
  • Stock Information
  • Founded
  • TERN 2017
  • HCAT 2008
  • Country
  • TERN United States
  • HCAT United States
  • Employees
  • TERN N/A
  • HCAT N/A
  • Industry
  • TERN Biotechnology: Pharmaceutical Preparations
  • HCAT Computer Software: Programming Data Processing
  • Sector
  • TERN Health Care
  • HCAT Technology
  • Exchange
  • TERN Nasdaq
  • HCAT Nasdaq
  • Market Cap
  • TERN 382.2M
  • HCAT 350.5M
  • IPO Year
  • TERN 2021
  • HCAT 2019
  • Fundamental
  • Price
  • TERN $4.43
  • HCAT $5.49
  • Analyst Decision
  • TERN Buy
  • HCAT Buy
  • Analyst Count
  • TERN 5
  • HCAT 11
  • Target Price
  • TERN $18.30
  • HCAT $11.27
  • AVG Volume (30 Days)
  • TERN 1.9M
  • HCAT 732.9K
  • Earning Date
  • TERN 03-13-2025
  • HCAT 02-20-2025
  • Dividend Yield
  • TERN N/A
  • HCAT N/A
  • EPS Growth
  • TERN N/A
  • HCAT N/A
  • EPS
  • TERN N/A
  • HCAT N/A
  • Revenue
  • TERN N/A
  • HCAT $302,062,000.00
  • Revenue This Year
  • TERN N/A
  • HCAT $6.04
  • Revenue Next Year
  • TERN N/A
  • HCAT $11.19
  • P/E Ratio
  • TERN N/A
  • HCAT N/A
  • Revenue Growth
  • TERN N/A
  • HCAT 4.15
  • 52 Week Low
  • TERN $4.32
  • HCAT $5.35
  • 52 Week High
  • TERN $11.40
  • HCAT $10.99
  • Technical
  • Relative Strength Index (RSI)
  • TERN 26.46
  • HCAT 25.45
  • Support Level
  • TERN $4.56
  • HCAT $6.83
  • Resistance Level
  • TERN $5.95
  • HCAT $7.65
  • Average True Range (ATR)
  • TERN 0.29
  • HCAT 0.47
  • MACD
  • TERN -0.10
  • HCAT -0.16
  • Stochastic Oscillator
  • TERN 3.17
  • HCAT 6.09

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: